Hui-ping Hsu
I Shou University Kaohsiung 824005
Shoufeng, TNQ 82400, Taiwan
Shoufeng, TNQ 82400, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
High plasma histidine concentration predicts a favorable prognosis in patients with ampullary cancer.
Journal: American journal of cancer research
Published: September 04, 2025
Suppression of STK11 induces expansion of polymorphonuclear myeloid-derived suppressive cells and activation of immune signaling in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: August 31, 2025
PCK2 promotes invasion and epithelial-to-mesenchymal transition in triple-negative breast cancer by promoting TGF-β/SMAD3 signaling through inhibiting TRIM67-mediated SMAD3 ubiquitination.
Journal: Cancer biology & therapy
Published: March 13, 2025
Premenopausal Patients With Clinically Aggressive Metastatic Breast Cancer Successfully Treated With a First-Line Palbociclib-Containing Regimen: Two Cases and Literature Review.
Journal: Cancer reports (Hoboken, N.J.)
Published: November 10, 2024
CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells.
Journal: Cancer & metabolism
Published: April 16, 2024
Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate.
Journal: American journal of cancer research
Published: June 26, 2023
ABCB1 Regulates Immune Genes in Breast Cancer.
Journal: Breast cancer (Dove Medical Press)
Published: June 08, 2023
Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 25, 2022
Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway.
Journal: International journal of medical sciences
Published: May 30, 2022
Last Updated: 09/26/2026